Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

64 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
PD-1/PD-L1 pathway: an adaptive immune resistance mechanism to immunogenic chemotherapy in colorectal cancer.
Dosset M, Vargas TR, Lagrange A, Boidot R, Végran F, Roussey A, Chalmin F, Dondaine L, Paul C, Lauret Marie-Joseph E, Martin F, Ryffel B, Borg C, Adotévi O, Ghiringhelli F, Apetoh L. Dosset M, et al. Among authors: vegran f. Oncoimmunology. 2018 Mar 15;7(6):e1433981. doi: 10.1080/2162402X.2018.1433981. eCollection 2018. Oncoimmunology. 2018. PMID: 29872568 Free PMC article.
The Tumor Microenvironment Impairs Th1 IFNγ Secretion through Alternative Splicing Modifications of Irf1 Pre-mRNA.
Bernard A, Hibos C, Richard C, Viltard E, Chevrier S, Lemoine S, Melin J, Humblin E, Mary R, Accogli T, Chalmin F, Bruchard M, Peixoto P, Hervouet E, Apetoh L, Ghiringhelli F, Végran F, Boidot R. Bernard A, et al. Among authors: vegran f. Cancer Immunol Res. 2021 Mar;9(3):324-336. doi: 10.1158/2326-6066.CIR-19-0679. Epub 2021 Jan 8. Cancer Immunol Res. 2021. PMID: 33419764 Free article.
Follicular helper-T cells restore CD8+-dependent antitumor immunity and anti-PD-L1/PD-1 efficacy.
Niogret J, Berger H, Rebe C, Mary R, Ballot E, Truntzer C, Thibaudin M, Derangère V, Hibos C, Hampe L, Rageot D, Accogli T, Joubert P, Routy B, Harker J, Vegran F, Ghiringhelli F, Chalmin F. Niogret J, et al. Among authors: vegran f. J Immunother Cancer. 2021 Jun;9(6):e002157. doi: 10.1136/jitc-2020-002157. J Immunother Cancer. 2021. PMID: 34103351 Free PMC article.
Recruitment and activation of type 3 innate lymphoid cells promote antitumor immune responses.
Bruchard M, Geindreau M, Perrichet A, Truntzer C, Ballot E, Boidot R, Racoeur C, Barsac E, Chalmin F, Hibos C, Baranek T, Paget C, Ryffel B, Rébé C, Paul C, Végran F, Ghiringhelli F. Bruchard M, et al. Among authors: vegran f. Nat Immunol. 2022 Feb;23(2):262-274. doi: 10.1038/s41590-021-01120-y. Epub 2022 Jan 31. Nat Immunol. 2022. PMID: 35102345
Impact of Lipid Metabolism on Antitumor Immune Response.
Mabrouk N, Lecoeur B, Bettaieb A, Paul C, Végran F. Mabrouk N, et al. Among authors: vegran f. Cancers (Basel). 2022 Apr 6;14(7):1850. doi: 10.3390/cancers14071850. Cancers (Basel). 2022. PMID: 35406621 Free PMC article. Review.
Hematopoietic Prostaglandin D2 Synthase Controls Tfh/Th2 Communication and Limits Tfh Antitumor Effects.
Mary R, Chalmin F, Accogli T, Bruchard M, Hibos C, Melin J, Truntzer C, Limagne E, Derangère V, Thibaudin M, Humblin E, Boidot R, Chevrier S, Arnould L, Richard C, Klopfenstein Q, Bernard A, Urade Y, Harker JA, Apetoh L, Ghiringhelli F, Végran F. Mary R, et al. Among authors: vegran f. Cancer Immunol Res. 2022 Jul 1;10(7):900-916. doi: 10.1158/2326-6066.CIR-21-0568. Cancer Immunol Res. 2022. PMID: 35612500
GTN Enhances Antitumor Effects of Doxorubicin in TNBC by Targeting the Immunosuppressive Activity of PMN-MDSC.
Mabrouk N, Racoeur C, Shan J, Massot A, Ghione S, Privat M, Dondaine L, Ballot E, Truntzer C, Boidot R, Hermetet F, Derangère V, Bruchard M, Végran F, Chouchane L, Ghiringhelli F, Bettaieb A, Paul C. Mabrouk N, et al. Among authors: vegran f. Cancers (Basel). 2023 Jun 9;15(12):3129. doi: 10.3390/cancers15123129. Cancers (Basel). 2023. PMID: 37370739 Free PMC article.
64 results